Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain microRNAs found in normal cells can effectively suppress various cancers.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

TLR3 activation helps improve skin and hair follicle healing in mice.

Cancer prevention has advanced significantly, with some strategies proving successful.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

A specific RNA increases hair stem cell growth and skin healing by affecting a protein through interaction with a microRNA.

EPI-NCSCs from hair follicles may help treat brain development issues in mice.

Nanotechnology shows promise for better drug delivery and cancer treatment.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

CRISPR-based tools improve understanding and treatment of skin development and conditions.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

MM-CEP/NLCs could effectively treat lung inflammation.

Researchers found genes and microRNAs that control curly fleece in Chinese Tan sheep.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Using old drugs for new uses can help treat rare immune deficiencies.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

RTA 408 cream protects mice from radiation skin damage.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Gene and cell therapies are being developed to treat rare skin conditions like epidermolysis bullosa and ichthyosis.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.